Your search for ‘Fulbright & Jaworski’ returned 1,029 results

By a two-to-one majority, the Quebec Court of Appeal recently ruled1 that a finding of the Commission des lésions professionnelles (CLP) according to which a worker had not been the victim of psychological harassment and thus did not suffer an employment injury within the meaning of the Act respecting industrial accidents and occupational diseases

The federal government recently tabled its newly developed Extractive Sector Transparency Measures Act.

The Canadian Securities Administrators will adopt new rules on permissible pre-marketing and marketing activities in connection with the public offering of securities in Canada.

Previously announced amendments to the Patented Medicines (Notice of Compliance) Regulations (PM(NOC) Regulations) were registered and brought into force on June 19, 2015 (the Amendments).

The Federal Court of Appeal released two decisions with respect to proceedings commenced pursuant to the "Patented Medicines (Notice of Compliance) Regulations".

O'Brien involved a proposed products liability class action. The defendants manufactured pelvic mesh products, 19 of which were involved in the proposed class action.

The Law Commission of Ontario (LCO) recently released a list of issues to be considered as part of its comprehensive review of Ontario’s Class Proceedings Act, 1992 (CPA).

The Federal Court found that failure to pay the correct "final fee" owing prior to patent grant was not a basis to invalidate a subsequently issued patent.

On October 31, 2013, the Supreme Court of Canada released its decisions in three related appeals, two from the British Columbia Court of Appeal and one from the Quebec Court of Appeal, all dealing with the certification of price-fixing claims as class actions.

Following its approval in December 2012 of two high-profile transactions involving foreign state-owned enterprises acquiring Canadian businesses, the Canadian government announced new policies that would guide the minister of industry in applying the Investment Canada Act (ICA) to subsequent similar transactions.

Since taking over from Melanie Aitken as Interim Commissioner of Competition six months ago, John Pecman has used the many forums afforded to him to clarify what the priorities of the Competition Bureau will be during his tenure.

On March 14, 2013, the Canadian Securities Administrators (CSA) published for comment proposed National Instrument 62-105 Security Holder Rights Plans and related companion policy (the Proposed Instrument).

On February 13, 2013, the Quebec government tabled a draft regulation (Draft Regulation) to amend the rules for financial guarantees set out in the Regulation respecting mineral substances other than petroleum, natural gas and brine (Regulation).

A discussion on a recent case where the Supreme Court of Canada has clearly ruled that the duty to consult exists to protect the collective rights of Aboriginal Peoples and that this duty is owed to the community that holds the rights.

An Alberta court directly disagreed with Ontario decisions on the appropriate factors to consider when a non-resident defendant challenges the jurisdiction of a Canadian court.

Canada has announced its intention to introduce new legislation mandating the disclosure of payments made by mining companies.

The Federal Court held that Merck and Co., Inc. ("Merck US") and Merck Canada Inc. ("Merck Canada") (collectively "Merck") are entitled to $119,054,327 in damages plus pre and post judgment interest arising from Apotex Inc.’s ("Apotex") infringement of Canadian Patent No 1,161,380 (the "‘380 Patent") with respect to the anti-cholesterol drug MEVACOR (lovastatin).

According to a recent MergerMarket Group report, the first 11 months of 2015 saw global deal value reach USD $3.88tn, surpassing global deal value for the entirety of 2014.